Your browser doesn't support javascript.
loading
Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern.
Lien, Chia-En; Kuo, Tsun-Yung; Lin, Yi-Jiun; Lian, Wei-Cheng; Lin, Meei-Yun; Liu, Luke Tzu-Chi; Cheng, Jinyi; Chou, Yu-Chi; Chen, Charles.
Afiliação
  • Lien CE; Medigen Vaccine Biologics Corporation, Taipei City, Taiwan.
  • Kuo TY; Institute of Public Health, National Yang-Ming Chiao Tung University, Taipei City, Taiwan.
  • Lin YJ; Department of Biotechnology and Animal Science, National Ilan University, Yilan County, Taiwan.
  • Lian WC; Medigen Vaccine Biologics Corporation, Taipei City, Taiwan.
  • Lin MY; Medigen Vaccine Biologics Corporation, Taipei City, Taiwan.
  • Liu LT; Medigen Vaccine Biologics Corporation, Taipei City, Taiwan.
  • Cheng J; Medigen Vaccine Biologics Corporation, Taipei City, Taiwan.
  • Chou YC; Medigen Vaccine Biologics Corporation, Taipei City, Taiwan.
  • Chen C; Biomedical Translation Research Center, Academia Sinica, Taipei City, Taiwan.
Clin Infect Dis ; 74(11): 1899-1905, 2022 06 10.
Article em En | MEDLINE | ID: mdl-34739037
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Clinical_trials Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Clinical_trials Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article